April 19, 2022 07:05 ET | Source: Novozymes A/S Novozymes A/S
Please read the full announcement in the attached PDF
Attachment
COPENHAGEN, Denmark – February 26, 2026. Novonesis delivered strong organic sales growth of 7% and an adjusted EBITDA margin of 37.1% in 2025. The company expects a good start to 2026 and a good year...
Please read the full announcement in PDF Attachment 2026_02_LTI ...